Graule, J., Uth, K., Fischer, E., Centeno, I., Galván, J. A., Eichmann, M., . . . Zlobec, I. (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clin Epigenetics.
Citação norma ChicagoGraule, Janina, et al. "CDX2 in Colorectal Cancer Is an Independent Prognostic Factor and Regulated By Promoter Methylation and Histone Deacetylation in Tumors of the Serrated Pathway." Clin Epigenetics 2018.
Citação norma MLAGraule, Janina, et al. "CDX2 in Colorectal Cancer Is an Independent Prognostic Factor and Regulated By Promoter Methylation and Histone Deacetylation in Tumors of the Serrated Pathway." Clin Epigenetics 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.